Literature DB >> 17261317

The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice.

Alasdair M Barr1, Kenneth N Fish, Athina Markou.   

Abstract

Postmortem brain loss of reelin is noted in schizophrenia patients. Accordingly, heterozygous reeler mutant mice have been proposed as a putative model of this disorder. Little is known, however, about the involvement of the two receptors for reelin, Very-Low-Density Lipoprotein Receptor (VLDLR) and Apolipoprotein E Receptor 2 (ApoER2), on pre-cognitive processes of relevance to deficits seen in schizophrenia. Thus, we evaluated sensorimotor gating in mutant mice heterozygous or homozygous for the two reelin receptors. Mutant mice lacking one of these reelin receptors were tested for prepulse inhibition (PPI) of the acoustic startle reflex prior to and following puberty, and on a crossmodal PPI task, involving the presentation of acoustic and tactile stimuli. Furthermore, because schizophrenia patients show increased sensitivity to N-methyl-d-aspartate (NMDA) receptor blockade, we assessed the sensitivity of these mice to the PPI-disruptive effects of the NMDA receptor antagonist phencyclidine. The results demonstrated that acoustic PPI did not differ between mutant and wildtype mice. However, VLDLR homozygous mice displayed significant deficits in crossmodal PPI, while ApoER2 heterozygous and homozygous mice displayed significantly increased crossmodal PPI. Both ApoER2 and VLDLR heterozygous and homozygous mice exhibited greater sensitivity to the PPI-disruptive effects of phencyclidine than wildtype mice. These results indicate that partial or complete loss of either one of the reelin receptors results in a complex pattern of alterations in PPI function that includes alterations in crossmodal, but not acoustic, PPI and increased sensitivity to NMDA receptor blockade. Thus, reelin receptor function appears to be critically involved in crossmodal PPI and the modulation of the PPI response by NMDA receptors. These findings have relevance to a range of neuropsychiatric disorders that involve sensorimotor gating deficits, including schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17261317      PMCID: PMC1861840          DOI: 10.1016/j.neuropharm.2006.11.011

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  46 in total

1.  Preferential alterations in the mesolimbic dopamine pathway of heterozygous reeler mice: an emerging animal-based model of schizophrenia.

Authors:  Martina Ballmaier; Michele Zoli; Giuseppina Leo; Luigi Francesco Agnati; PierFranco Spano
Journal:  Eur J Neurosci       Date:  2002-04       Impact factor: 3.386

Review 2.  Neuronal calcium-binding proteins and schizophrenia.

Authors:  D W Eyles; J J McGrath; G P Reynolds
Journal:  Schizophr Res       Date:  2002-09-01       Impact factor: 4.939

3.  Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness.

Authors:  K Sawada; C E Young; A M Barr; K Longworth; S Takahashi; V Arango; J J Mann; A J Dwork; P Falkai; A G Phillips; W G Honer
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 4.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

Review 5.  Mouse genetic models for prepulse inhibition: an early review.

Authors:  M A Geyer; K L McIlwain; R Paylor
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

6.  Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm.

Authors:  N R Swerdlow; B Karban; Y Ploum; R Sharp; M A Geyer; A Eastvold
Journal:  Biol Psychiatry       Date:  2001-10-15       Impact factor: 13.382

7.  Withdrawal from chronic phencyclidine treatment induces long-lasting depression in brain reward function.

Authors:  Cecile Spielewoy; Athina Markou
Journal:  Neuropsychopharmacology       Date:  2003-03-26       Impact factor: 7.853

Review 8.  Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies.

Authors:  D L Braff; M A Geyer; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2001-07       Impact factor: 4.530

9.  Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning.

Authors:  Edwin J Weeber; Uwe Beffert; Chris Jones; Jill M Christian; Eckart Forster; J David Sweatt; Joachim Herz
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

10.  Immunocytochemical localization of reelin in the olfactory bulb of the heterozygous reeler mouse: an animal model for schizophrenia.

Authors:  George D Pappas; Virginia Kriho; Wen-Sheng Liu; Lucio Tremolizzo; Giovanni Lugli; John Larson
Journal:  Neurol Res       Date:  2003-12       Impact factor: 2.448

View more
  9 in total

Review 1.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

2.  Age-associated improvements in cross-modal prepulse inhibition in mice.

Authors:  Jared W Young; Chelsea K Wallace; Mark A Geyer; Victoria B Risbrough
Journal:  Behav Neurosci       Date:  2010-02       Impact factor: 1.912

3.  Genome-wide association study of a quantitative disordered gambling trait.

Authors:  Penelope A Lind; Gu Zhu; Grant W Montgomery; Pamela A F Madden; Andrew C Heath; Nicholas G Martin; Wendy S Slutske
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

Review 4.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

5.  Replication of association between working memory and Reelin, a potential modifier gene in schizophrenia.

Authors:  Juho Wedenoja; Annamari Tuulio-Henriksson; Jaana Suvisaari; Anu Loukola; Tiina Paunio; Timo Partonen; Teppo Varilo; Jouko Lönnqvist; Leena Peltonen
Journal:  Biol Psychiatry       Date:  2009-11-17       Impact factor: 13.382

Review 6.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

7.  Functional consequences of hippocampal neuronal ectopia in the apolipoprotein E receptor-2 knockout mouse.

Authors:  Kenneth N Fish; Thomas Krucker
Journal:  Neurobiol Dis       Date:  2008-08-15       Impact factor: 5.996

8.  Neurotrophins regulate ApoER2 proteolysis through activation of the Trk signaling pathway.

Authors:  Jorge A Larios; Ignacio Jausoro; Maria-Luisa Benitez; Francisca C Bronfman; Maria-Paz Marzolo
Journal:  BMC Neurosci       Date:  2014-09-19       Impact factor: 3.288

Review 9.  Reelin and Neuropsychiatric Disorders.

Authors:  Kazuhiro Ishii; Ken-Ichiro Kubo; Kazunori Nakajima
Journal:  Front Cell Neurosci       Date:  2016-10-18       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.